Assessing and Management of Neurotoxicity After CAR-T Therapy in Diffuse Large B-Cell Lymphoma #lymphoma #lymsm https://t.co/x9vDlotiRk
New article: Assessing and Management of Neurotoxicity After CAR-T Therapy in Diffuse Large B-Cell Lymphoma https://t.co/GoJaDjgycW #DLBCL #lymsm #hematology https://t.co/aEGjY1HX7g
RT @investak3: $HGEN https://t.co/AvN4bZxadL Great peer-review article about the efficacy of Lenzilumab in follow-up care of CAR-T therapy.…
$HGEN https://t.co/AvN4bZxadL Great peer-review article about the efficacy of Lenzilumab in follow-up care of CAR-T therapy. The role of GM-CSF in CAR-T is also getting obvious day by day. What we need is only the time and a little more patience. https://t
Assessing and Management of Neurotoxicity After CAR-T Therapy in Diffuse Large B-Cell Lymphoma https://t.co/YG3n0RMZ5p @dovepress #CAR-T